[Beta blockers after myocardial infarct: patients with low and high risk factors benefit equally].
Medizinische Poliklinik Universitätsspital, Zürich.
P
P
Ritzmann
D000319:Adrenergic beta-Antagonists / Q000009:adverse effects / Q000627:therapeutic use*; D000368:Aged; D015331:Cohort Studies; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000188:drug therapy* / Q000401:mortality; D012189:Retrospective Studies; D012307:Risk Factors; D015996:Survival Rate
D000319:Adrenergic beta-Antagonists
Betablocker nach Myokardinfarkt: Personen mit niedrigem und hohem Risiko scheinen in ähnlichem Ausmass zu profitieren.